文献速递头颈外科

更新甲状腺髓样癌初治患者基础降钙素水平预测淋巴结转移范围的阈值

Updated Thresholds of Basal Calcitonin Level and Extent of Lymph Node Metastasis in Initially Treated Medullary Thyroid Cancer.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2025-01-01

这项回顾性队列研究纳入中国13家医院2011至2024年初治甲状腺髓样癌患者509例,用电化学发光或化学发光法检测术前基础降钙素,随机按2:1分为训练集和验证集。研究识别出预测中央区、同侧侧颈、上纵隔及双侧和/或对侧侧颈淋巴结转移的降钙素阈值,并在两队列中显示所提阈值在预测淋巴结转移和区分无结构性复发生存方面均优于美国甲状腺协会指南推荐的阈值。

要点

  • 术前降钙素与淋巴结转移范围呈正相关(η2=0.28)。
  • 训练集识别中央区淋巴结转移阈值为241.9 pg/mL。
  • 同侧侧颈、上纵隔、双侧和/或对侧侧颈转移阈值分别为693.9、2787.1、2378.5 pg/mL。

核心结论

  • 更新的术前血清降钙素阈值可预测不同范围的淋巴结转移,可能为未来生物标志物指导的选择性颈清扫前瞻性研究提供最佳截断值。

研究设计与样本

  • 回顾性队列研究,纳入中国13家医院2011至2024年初治甲状腺髓样癌患者509例,术前基础降钙素用电化学发光或化学发光法检测,按2:1随机分为训练集和验证集,数据分析于2024年6月至2024年9月进行。

主要发现

  • 中位(四分位距)随访52(27-84)个月,诊断时中位(四分位距)年龄50(40-59)岁,女性279例(54.8%)。
  • 患者按淋巴结转移范围分为无淋巴结转移、中央区淋巴结转移、侧颈淋巴结转移和上纵隔淋巴结转移4组。
  • 术前降钙素水平与淋巴结转移范围呈正相关(η2=0.28)。
  • 训练集识别预测中央区淋巴结转移阈值为241.9 pg/mL,同侧侧颈淋巴结转移为693.9 pg/mL,上纵隔淋巴结转移为2787.1 pg/mL,双侧和/或对侧侧颈淋巴结转移为2378.5 pg/mL。
  • 在训练集和验证集中,所提阈值在预测淋巴结转移和区分无结构性复发生存方面均优于美国甲状腺协会指南推荐的阈值。

关键数值与推荐

  • 中央区淋巴结转移阈值241.9 pg/mL。
  • 同侧侧颈淋巴结转移阈值693.9 pg/mL。
  • 上纵隔淋巴结转移阈值2787.1 pg/mL。
  • 双侧和/或对侧侧颈淋巴结转移阈值2378.5 pg/mL。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Calcitonin is the most sensitive and specific biomarker for medullary thyroid cancer (MTC). Basal serum calcitonin levels are strongly associated with the burden of lymph node metastasis (LNM) and can help guide the extent of neck dissection. However, the predictive thresholds for varying degrees of LNM are based on laboratory testing methods no longer in use. OBJECTIVE: To update the optimal thresholds of basal serum calcitonin levels for predicting the extent of LNM. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included initially treated patients with MTC who had their preoperative basal calcitonin levels tested using electrochemiluminescence or chemiluminescence from a Chinese multicenter cohort of 13 hospitals between 2011 and 2024. The patients were randomly divided into a training and a validation cohort in a 2:1 ratio. The data were analyzed between June 2024 and September 2024. EXPOSURES: Preoperative basal serum calcitonin using electrochemiluminescence or chemiluminescence. MAIN OUTCOMES AND MEASURES: The main outcome is Structural recurrence-free survival (SRFS) based on the group partitioned by the proposed thresholds predicting different LNMs. RESULTS: A total of 509 patients were included in the study with a median (interquartile range [IQR]) follow-up of 52 (27-84) months. The median (IQR) age at diagnosis was 50 (40-59) years, and 279 patients (54.8%) were female individuals. Patients were categorized into 4 groups based on the extent of LNM: no LNM, central LNM, lateral LNM, and upper mediastinal LNM. A positive correlation was found between preoperative calcitonin levels and the extent of LNM (η2 = 0.28). Using the training cohort, preoperative basal calcitonin thresholds associated with different extents of LNM were identified as follows: 241.9 pg/mL for central LNM, 693.9 pg/mL for ipsilateral lateral LNM, 2787.1 pg/mL for upper mediastinal LNM, and 2378.5 pg/mL for bilateral and/or contralateral lateral LNM. In both the training and validation cohorts, the proposed thresholds outperformed those recommended by the American Thyroid Association guidelines not only in the prediction of LNM, but also in the discrimination of SRFS. CONCLUSIONS: In this cohort study, updated threshold values of preoperative serum calcitonin predicted different extents of LNM, which may provide optimal cutoffs for future prospective studies on biomarker-guided selective neck dissection in patients with MTC.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Du Y, Shen C, Song K, et al. Updated Thresholds of Basal Calcitonin Level and Extent of Lymph Node Metastasis in Initially Treated Medullary Thyroid Cancer. JAMA Otolaryngol Head Neck Surg. 2025. PMID: 40569620. doi:10.1001/jamaoto.2025.0542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。